Ceribell, Inc.
corporate_fare Company Profile
Ceribell, Inc. (NASDAQ:CBLL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for CBLL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for CBLL spans 10-Q, 8-K, 144, 10-K.
Recent high-impact activity:
- Ceribell 10-Q Details Q3: Revenue $29.3M, Loss Widens to $21.4M, Cash $117.5M
- Ceribell Tops $29.3M Revenue, Lifts 2026 Guidance to $115M-$117M
- Ceribell Launches First FDA-Cleared Delirium Monitor With $2,171 CMS Add-On Payment
- Ceribell Q2 Revenue Beats, Guidance Raised; New Credit Facility and FDA Clearances Disclosed
- Ceribell Tops Q2 Revenue, Lifts Full-Year Outlook, and Locks In $60M Credit Facility
Financial Snapshot
Short Interest & Short Volume
3.55 days to coverFINRA reported short interest of 1,956,647 shares in CBLL as of the October 30, 2026 settlement, a 9.2% decrease from the prior period — about 3.5 days to cover at its recent average daily volume. On November 19, 2026, 64.8% of CBLL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.